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General Experimental Section.  NMR spectra were recorded on either a 500 MHz or a
300 MHz NMR spectrometer.  Chemical shifts are reported in parts per million (ppm)
downfield from tetramethylsilane (TMS) with reference to internal solvent.  Multiplicities
are abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quint),
multiplet (m), and broad (br).  The reported 1H NMR and 13C NMR data refer to the
major olefin isomer (which is identified) except for cases in which the minor isomer
showed significantly prominant peaks, in which case both isomers are characterized.  It
should be noted that, for all vinyl boronates reported, the 13C peak for the a-carbon atom
is not visible, due to the large quadrupolar effect of the attached boron nucleus.i
Analytical thin-layer chromatography (TLC) was performed using silica gel 60
F254 precoated plates (0.25 mm thickness) with a fluorescent indicator.  Visualization
was performed with standard potassium permangate stains.  Flash column
chromatography was performed using silica gel 60 (230-400 mesh).  All commercial
chemicals were used as obtained unless noted otherwise.  Diethyl ether and
dichloromethane were purified and dried by passage through a solvent column.ii
1-Octenylboronic acid (7).  The crude product was purified using column
chromatography (3:2 hexane:ethyl acetate).  1H NMR (500 MHz, CDCl3, ppm):  (cyclic
trimer, E-isomer) d  6.97 (3H, dt, J = 18.0, 6.4 Hz), 5.54 (3H, d, J = 18.0 Hz), 2.22 (6H,
dt, J = 7.0, 7.0 Hz),1.4 (24H, m), 0.9 (9H, m).  (monomeric acid, E-isomer):  d 6.52 (1H,
dt, 18.0, 6.4 Hz), 5.41 (1H, d, J = 17.5 Hz), 4.20 (2H, br), 2.17 (2H, dt, J = 7.0, 7.0 Hz),
1.4 (8H, m), 0.9 (3H, m).  13C NMR (300 MHz, CDCl3, ppm):  (cyclic trimer, E-isomer)
d 158.0, 36.0, 32.0, 29.2, 28.5, 22.9, 14.4.  HRMS (EI) calcd. for C24H45B3O3:  414.3648,
found:  414.3635.
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3-(Triisopropyl-silanyl)-1-propenylboronic acid (8).  The crude product was purified
using column chromatography (7:3 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3,
ppm):  (cyclic trimer, E-isomer) d  7.10 (3H, dt, J = 17.1, 8.5 Hz), 5.43 (3H, d, J = 17.1
Hz), 1.90 (6H, d, J = 7.8 Hz), 1.082 (54H, s), 1.075 (9H, s).  13C NMR (300 MHz, CDCl3,
ppm):  (cyclic trimer, E-isomer)  d 156.1, 21.5, 19.0, 11.4.  HRMS (CI) calcd. for C12H-
27BO2Si:  242.1873, found:  242.1877; calcd. for C36H75B3O3Si3 + H:  673.5382, found:
673.5382.
4,4,5,5-Tetramethyl-2-[3-(triisopropyl-silanyl)-propenyl]-[1,3,2]dioxaborolane (9).
The crude product was purified using column chromatography (19:1 hexane:ethyl
acetate).  1H NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 6.76 (1H, dt, J = 17.7, 8.3
Hz), 5.33 (1H, dt, J = 17.4, 1.1 Hz), 1.81 (2H, dd, J = 8.3, 1.1 Hz), 1.25 (12H, s), 1.06
(18H, s), 1.05 (3H, s).  13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 153.3, 82.9,
25.0, 21.2, 19.0, 11.3.  HRMS (EI) calcd. for C18H37BO2Si:  324.2656, found:  324.2660.
Acetic acid 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-hex-5-enyl ester (10).
The crude product was purified using column chromatography (4:1 hexane:ethyl acetate).
1H NMR (300 MHz, CDCl3, ppm): (E-isomer)  d 6.60 (1H, dt, J = 17.7, 6.4 Hz), 5.43
(1H, dt, J = 18.0, 1.5 Hz), 4.04 (2H, t, J = 6.5 Hz), 2.17 (2H, ddt, J = 6.7, 6.7, 1.7 Hz),
2.03 (3H, s), 1.65 (2H, m), 1.50 (2H, m), 1.25 (12H, s).  13C NMR (300 MHz, CDCl3,
ppm):  (E-isomer)  d 171.4, 153.9, 83.2, 64.5, 35.4, 28.3, 25.0, 24.7, 21.2.  HRMS (EI)
calcd. for C14H25BO4:  268.1846, found:  268.1854.
4,4,5,5-Tetramethyl-2-oct-1-enyl-[1,3,2]dioxaborolane (11).  The crude product was
purified using column chromatography (19:1 hexane:ethyl acetate).  1H NMR (300 MHz,
CDCl3, ppm):  (E-isomer)  d 6.64 (1H, dt, J = 18.3, 6.5 Hz), 5.43 (1H, J = 18.3, 1.7 Hz),
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2.16 (2H, dtd, J = 7.0, 7.0, 1.8 Hz), 1.4 (8H, m), 1.28 (12H, s), 0.89 (3H, t, J = 6.9 Hz).
13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 155.1, 83.2, 36.1, 31.9, 29.1, 28.4,
25.0, 22.8, 14.3.  HRMS (EI) calcd. for C14H27BO2:  238.2104, found:  238.2109.
2-(2-Cyclopentyl-vinyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (12a).  The crude
product was purified using column chromatography (19:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 6.62 (1H, dd, J = 17.9, 7.4 Hz), 5.37 (1H,
dd, J = 17.7, 1.2 Hz), 2.5 (1H, m), 1.7 (6H, m), 1.4 (1H, m), 1.28 (12H, s), 1.1 (1H, m).
13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d  159.2, 83.2, 46.4, 32.6, 25.5, 25.0.
HRMS (CI) calcd. for C13H23BO2:  222.1791, found:  222.1799.
2-(2-Cyclohexyl-vinyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (12b).  The crude
product was purified using column chromatography (19:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3 ppm):  (E-isomer)  d 6.58 (1H, dd, J = 18.2, 6.2 Hz), 5.38 (1H,
dd, J = 18.3, 1.5 Hz), 2.0 (1H, m), 1.6 (5H, m), 1.27 (12H, s), 1.2 (5H, m).  13C NMR
(300 MHz, CDCl3, ppm):  (E-isomer)  d 160.1, 83.2, 43.5, 32.1, 26.4, 26.2, 25.0.  HRMS
(EI) calcd. for C14H25BO2:  236.1948, found:  236.1956.
2-Cyclopentylidenemethyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (13a).  The crude
product was purified using column chromatography (19:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3, ppm):  d 5.28 (1H, quint, J = 2.2 Hz), 2.53 (2H, t, J = 7.5 Hz),
2.37 (2H, t, J = 6.8 Hz), 1.65 (4H, m), 1.26 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):
d 172.2, 112.5, 82.7, 37.2, 33.5, 27.0, 26.1, 25.1.  HRMS (EI) calcd. for C12H21BO2:
208.1635, found:  208.1627.
2-Cyclohexylidenemethyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (13b).  The crude
product was purified using column chromatography (19:1 hexane:ethyl acetate).  1H
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NMR (300 MHz, CDCl3, ppm):  d 5.02 (1H, s), 2.52 (2H, t, J = 6.3 Hz), 2.20 (2H, t, J =
5.6 Hz), 1.57 (6H, m), 1.26 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):  d 167.2, 82.7,
40.3, 33.4, 28.9, 28.7, 26.6, 25.0.  HRMS (EI) calcd. for C13H23BO2:  222.1791, found:
222.1790.
4,4,5,5-Tetramethyl-2-styryl-[1,3,2]dioxaborolane (14a).  The crude product was
purified using column chromatography (9:1 hexane:ethyl acetate).  1H NMR (300 MHz,
CDCl3, ppm):  (E-isomer)  d 7.50 (2H, dd, J = 7.8, 1.5 Hz), 7.41 (1H, d, J = 19.2 Hz), 7.3
(3H, m), 6.18 (1H, d, J = 18.6 Hz), 1.33 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):
(E-isomer)  d 149.7, 137.7, 129.1, 128.8, 127.3, 83.6, 25.0.  HRMS (EI) calcd. for
C14H19BO2:  230.1478, found:  230.1473.
 2-[2-(2-Bromo-phenyl)-vinyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (14b).  The
crude product was purified using column chromatography (9:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 7.72 (1H, d, J = 18.3 Hz), 7.62 (1H, dd, J
= 8.0, 1.7 Hz), 7.56 (1H, dd, J = 7.8, 1.2 Hz), 7.30 (1H, ddd, J = 6.9, 6.9, 0.6 Hz), 7.15
(1H, ddd, J = 7.5, 7.5, 1.8 Hz), 6.13 (1H, d, J = 18.3 Hz), 1.33 (12H, s).  13C NMR (300
MHz, CDCl3, ppm):  (E-isomer)  d 147.7, 137.6, 133.3, 130.1, 127.7, 127.5, 124.5, 83.7,
25.0.  HRMS (EI) calcd. for C14H18BBrO2:  308.0583, found:  308.0589.
 4,4,5,5-Tetramethyl-2-[2-(3-nitro-phenyl)-vinyl]-[1,3,2]dioxaborolane (14c).  The
crude product was purified using column chromatography (4:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CD2Cl2, ppm):  (E-isomer)  d 8.32 (1H, s), 8.12 (1H, d, J = 8.3 Hz),
7.81 (1H, d, J = 7.5 Hz), 7.53 (1H, dd, J = 7.8, 7.8 Hz), 7.39 (1H, d, J = 18.6 Hz), 6.29
(1H, d, J = 18.3 Hz), 1.29 (12H, s).  13C NMR (300 MHz, CD2Cl2, ppm):  (E-isomer)  d
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149.2, 146.9, 139.8, 133.3, 130.2, 123.7, 122.0, 84.2, 25.2.  HRMS (EI) calcd. for
C14H18BNO4:  275.1329, found:  275.1330.
 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-but-3-en-2-ol (16).  The
crude product was purified using column chromatography (7:3 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 6.72 (1H, d, J = 18.0 Hz), 5.61 (1H, d, J =
18.3 Hz), 1.58 (1H, br), 1.32 (6H, s), 1.29 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):
(E-isomer)  d 160.0, 83.5, 72.0, 29.3, 25.0.  HRMS (EI) calcd. for C11H21BO3 – CH3:
197.1349, found:  197.1348.
 Benzoic acid 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-but-3-enyl ester (17).
The crude product was purified using column chromatography (9:1 hexane:ethyl acetate).
1H NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 8.04 (2H, dd, J = 8.4, 1.5 Hz), 7.56
(1H, tt, J = 7.4, 1.8 Hz), 7.44 (2H, dd, J = 8.1, 6.6 Hz), 6.67 (1H, dt, J = 17.4, 6.3 Hz),
5.61 (1H, dt, J = 18.3, 1.5 Hz), 4.41 (2H, t, J = 6.9 Hz), 2.65 (2H, ddd, J = 6.6, 6.6, 1.2
Hz), 1.28 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 166.8, 149.2,
133.1, 130.5, 129.8, 128.5, 83.4, 63.7, 35.2, 25.0.  HRMS (EI) calcd. for C14H25BO2:
302.1689, found:  302.1683.
Benzoic acid 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-allyl ester (19).  The
crude product was purified using column chromatography (4:1 hexane:ethyl acetate).  1H
NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 8.08, 2H, d, J = 7.2 Hz), 7.57 (1H, t, J =
7.4 Hz), 7.44 (2H, dd, J = 7.5, 7.5 Hz), 6.74 (1H, dt, J = 18.3, 4.4 Hz), 5.79 (1H, dt, J =
18.3, 2.0 Hz), 4.92 (2H, dd, J = 4.4, 1.7 Hz), 1.28 (12H, s).  13C NMR (300 MHz, CDCl3,
ppm):  (E-isomer)  d 166.3, 146.2, 133.2, 130.2, 129.9, 128.6, 83.7, 65.9, 25.0.  HRMS
(EI) calcd. for C16H21BO4:  288.1533, found:  288.1534.
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2-[3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-allyl]-isoindole-1,3-dione (21).
The crude product was purified using column chromatography (7:3 hexane:ethyl acetate).
1H NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 7.85 (2H, dd, J = 5.7, 3.3 Hz), 7.72
(2H, dd, J = 5.6, 2.9 Hz), 6.59 (1H, dt, J = 18.0, 4.4 Hz), 5.48 (1H, dt, J = 18.3, 1.7 Hz),
4.39 (2H, dd, J = 4.5, 1.5 Hz), 1.23 (12H, s).  13C NMR (300 MHz, CDCl3, ppm):  (E-
isomer)  d 167.8, 145.3, 134.1, 132.1, 123.4, 83.6, 41.2, 25.0.  HRMS (EI) calcd. for
C17H20BNO4:  313.1485, found:  313.1476.
 1-Bromo-oct-1-ene (22).  The crude product was purified using column chromatography
(pure hexanes).  1H NMR (300 MHz, C6D6, ppm):  (Z-isomer)  d 5.85 (1H, dt, J = 7.2, 1.4
Hz), 5.66 (1H, dt, J = 6.9, 6.9 Hz), 2.09 (2H, dtd, J = 7.1, 7.1, 1.4 Hz), 1.2 (8H, m), 0.57
(3H, t, J = 6.9 Hz).  (E-isomer) d 5.97 (1H, dt, J = 13.5, 7.4 Hz), 5.70 (1H, dt, J = 13.8,
1.5 Hz), 2.09 (2H, dtd, J = 7.1, 7.1, 1.4 Hz), 1.2 (8H, m), 0.57 (3H, t, J = 6.9 Hz).  13C
NMR (300 MHz, CDCl3, ppm):  (Z-isomer)  d 135.2, 107.7, 31.9, 30.0, 29.1, 28.4, 22.9,
14.1.  HRMS calcd. for C8H15Br:  190.0357, found:  190.0360.
Acetic acid 6-bromo-hex-5-enyl ester (23).  The crude product was purified using
column chromatography (9:1 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3, ppm):
(Z-isomer)  d 6.18 (1H, d, J = 7.5 Hz), 6.09 (1H, dt, J  = 6.8, 6.8 Hz), 4.08 (2H, t, J = 6.6
Hz), 2.24 (2H, dt, J = 7.3, 7.3 Hz), 2.05 (3H, s), 1.7 (2H, m), 1.5 (2H, m).  13C NMR (300
MHz, CDCl3, ppm):  (Z-isomer)  d 171.4, 134.5, 108.5, 64.4, 29.5, 28.3, 24.8, 21.2.  (E-
isomer) d 137.7, 105.0, 64.3, 32.7, 28.1, 25.2.  HRMS (EI) calcd. for C8H13BrO2:
220.0099, found:  220.0104
1-(2-Bromo-vinyl)-3-nitro-benzene (24).  The crude product was purified using column
chromatography (9:1 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3, ppm):  (Z-
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isomer)  d 8.56 (1H, dd, J = 2.0, 2.0 Hz), 8.20 (1H, dd, J = 8.3, 1.7 Hz), 8.00 (1H, d, J =
7.5 Hz), 7.57 (1H, dd, J = 8.0, 8.0 Hz), 7.15 (1H, d, J = 8.1 Hz), 6.65 (1H, d, J = 8.1 Hz).
13C NMR (300 MHz, CDCl3, ppm):  (Z-isomer)  d 148.4, 136.7, 134.9, 130.5, 129.4,
123.9, 123.2, 110.0.  HRMS (EI) calcd. for C11H8BrNO2:  226.9582, found:  226.9580.
Benzoic acid 4-bromo-but-3-enyl ester (25).  The crude product was purified using
column chromatography (19:1 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3, ppm):
(Z-isomer)  d 8.06 (2H, d, J = 6.6 Hz), 7.58 (1H, t, J = 7.5 Hz), 7.45 (2H, dd, J = 7.7, 7.7
Hz), 6.34 (1H, dt, J = 7.2, 1.2 Hz), 6.24 (1H, dt, J = 6.9, 6.9 Hz), 4.41 (2H, t, J = 6.5 Hz),
2.71 (2H, dtd, J = 6.7, 6.7, 1.4 Hz).  13C NMR (300 MHz, CDCl3, ppm):  (Z-isomer)  d
166.7, 133.2, 130.6, 130.3, 129.8, 128.9, 110.7, 63.1, 29.8.  HRMS (CI) calcd. for
C11H11BrO2 + H:  255.0021, found:  255.0009.
2-(3-Bromo-allyl)-isoindole-1,3-dione (26).  The crude product was purified using
column chromatography (4:1 hexane:ethyl acetate).  Further purification could be
obtained via recrystallization from hexanes.  1H NMR (300 MHz, CDCl3, ppm):  (Z-
isomer)  d 7.87 (2H, dd, J = 5.3, 3.2 Hz), 7.74 (2H, dd, J = 5.6, 3.2 Hz), 6.39 (1H, dt, J =
7.2, 1.7 Hz), 6.24 (1H, dt, J = 6.9, 6.2 Hz), 4.48 (2H, dd, J = 6.2, 1.4 Hz).  13C NMR (300
MHz, CDCl3, ppm):  (Z-isomer)  d 167.9, 134.3, 132.2, 129.1, 123.6, 111.1, 37.6.  HRMS
(CI) calcd. for C11H8BrNO2 + H:  265.9817, found:  265.9825.
(3-Iodo-allyl)-triisopropyl-silane (27).  The crude product was purified using column
chromatography (pure hexanes).  1H NMR (300 MHz, C6D6, ppm):  (E-isomer)  d 6.52
(1H, dt, J = 14.4, 8.6 Hz), 5.76 (1H, dt, J = 14.4, 1.3 Hz), 1.67 (2H, dd, J = 8.6, 1.4 Hz),
1.07 (18H, s), 1.06 (3H, s).  (Z-isomer) d 6.25 (1H, dt, J = 7.7, 7.7 Hz), 6.01 (1H, dt, J =
7.2, 1.4 Hz), 1.75 (2H, dd, J = 8.0, 1.4 Hz), 1.10 (21H, s).  13C NMR (300 MHz, CDCl3,
  S8
ppm):  (E-isomer)  d 143.9, 70.7, 20.4, 18.9, 11.2.  (Z-isomer) d 139.1, 80.5, 30.0, 19.0,
11.6.  HRMS (EI) calcd. for C12H25SiI:  324.0770, found:  324.0775.
1-Iodo-oct-1-ene (28).  The crude product was purified using column chromatography
(19:1 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 6.52 (1H,
dt, J = 14.1, 7.1 Hz), 5.98 (1H, dt, J = 14.1, 1.4 Hz), 2.06 (2H, dtd, J = 7.2, 7.2, 1.2 Hz),
1.4 (8H, m), 0.90 (3H, t, J = 6.6 Hz).  13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d
146.9, 74.5, 36.4, 31.9, 28.9, 28.6, 22.9, 14.4.  HRMS (CI) calcd. for C8H15I:  238.0218,
found:  238.0224.
(2-Iodo-vinyl)-benzene (29).  The crude product was purified using column
chromatography (pure hexanes).  1H NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 7.45
(1H, d, J = 14.7 Hz), 7.3 (5H, m), 6.84 (1H, d, J = 15.0 Hz).  13C NMR (300 MHz,
CDCl3, ppm):  (E-isomer)  d 145.0, 137.7, 128.8, 128.5, 126.1, 76.9.  HRMS (CI) calcd.
for C8H7I:  229.9592, found:  229.9592.
4-Iodo-2-methyl-but-3-en-2-ol (30).  The crude product was purified using column
chromatography (4:1 hexane:ethyl acetate).  1H NMR (300 MHz, CDCl3, ppm):  (E-
isomer)  d 6.68 (1H, d, J = 14.1 Hz), 6.34 (1H, d, J = 14.7 Hz), 1.71 (1H, br), 1.31 (6H,
s).  13C NMR (300 MHz, CDCl3, ppm):  (E-isomer)  d 153.1, 75.0, 74.0, 29.5.  HRMS
(CI) calcd. for C5H9IO:  211.9698, found:  211.9696.
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